
Aktiviere Job-Benachrichtigungen per E-Mail!
Erstelle in nur wenigen Minuten einen maßgeschneiderten Lebenslauf
Überzeuge Recruiter und verdiene mehr Geld. Mehr erfahren
A prominent cancer research center in Mainz seeks a Junior Research Group Leader to develop innovative anti-cancer cellular immunotherapies. The successful candidate will foster an interdisciplinary research environment and engage in leading scientific community efforts at its partner site. Essential qualifications include a PhD or MD, significant research experience, and strong publication records. Experience in translational cancer research is necessary. Applicants are encouraged to contribute to teaching and mentoring activities.
Junior Research Group Leader "Translation of Next Generation Anti-Cancer Cellular Immunotherapies“
Reference number: 2025-0281
Mainz
Full-time
DKTK partner site Frankfurt / Mainz - Department of Hematology and Medical Oncology at the UMC Mainz
The German Cancer Research Center (DKFZ) is one of Europe’s largest cancer research centers. "Research for a life without cancer" is the mission of our world‑class scientists and all our team members.
The DKFZ is a place where the brightest minds pursue bold ideas and seek answers to pioneering scientific questions through collaboration, innovation, and exploration across many disciplines. We provide a dynamic environment which empowers excellence with state‑of‑the‑art technologies, cutting‑edge infrastructure, and a global scientific network.
Contribute your knowledge, vision, and dedication to create a space where scientific discovery in cancer research is transformed into benefits for human health.
Together with university partners at seven renowned partner sites, we have established the German Cancer Consortium (DKTK).
For the DKTK partner site Frankfurt / Mainz, we are seeking the next possible date an independent junior research group leader with a strong background in cellular immunotherapies to match the scientific profile of the DKTK partner site Frankfurt / Mainz at the Mainz location. The group will be physically located at the Department of Hematology and Medical Oncology at the UMC Mainz.
We expect from the candidate a fully translational research program that fosters the interdisciplinary development of next‑generation gene‑modified immune cellular products targeting malignant disease and / or the tumor microenvironment. The successful candidate is expected to get engaged in the lively scientific community on the campus and to integrate constructively into joint translational scientific efforts at the DKTK partner site and beyond. Direct links to groups and departments involved in cellular therapy research should be fostered, which in turn will offer ample opportunity to develop a unique scientific portfolio.
The candidate should have a strong focus on targeted immunotherapy and bring together a vast set of diverse scientific methodologies. The new junior research group, therefore, should reflect this engaging spirit and will foster the development of relevant translational approaches.
Your applications should include: